Stockreport

InterCure Announces Preliminary Estimated 2023 Revenue of NIS 351 million and EBITDA of over NIS 50 million

Intercure Ltd.  (INCR) 
US:NASDAQ Investor Relations: investor.incresearch.com/investors
PDF Revenues for H2 2023 were affected by damages caused by the terrorist attack on October 7, 2023 and the war in Gaza. However, InterCure it is entitled to full compensati [Read more]